Annals of Emergency Medicine
Volume 49, Issue 5 , Pages 618-626 , May 2007

Initial Serum Glucose Level as a Prognostic Factor in the First Acute Myocardial Infarction

  • Chin-Wang Hsu, MD, MS

      Affiliations

    • Department of Emergency Medicine, Tri-Service General Hospital, Taipei, Taiwan
    • ,
  • Hsiu Hsi Chen, MD, PhD

      Affiliations

    • Institute of Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan
    • ,
  • Wayne H.-H. Sheu, MD, PHD

      Affiliations

    • Department of Medical Research and Education, Taichung Veterans General Hospital, Taipei, Taiwan.
    • ,
  • Shi-Jye Chu, MD

      Affiliations

    • Department of Emergency Medicine, Tri-Service General Hospital, Taipei, Taiwan
    • ,
  • Ying-Sheng Shen, MD

      Affiliations

    • Department of Emergency Medicine, Tri-Service General Hospital, Taipei, Taiwan
    • ,
  • Chin-Pyng Wu, MD, PHD

      Affiliations

    • Department of Emergency Medicine, Tri-Service General Hospital, Taipei, Taiwan
    • ,
  • Kuo-Liong Chien, MD, PhD

      Affiliations

    • Institute of Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan
    • Corresponding Author InformationAddress for reprints: Kuo-Liong Chien, MD, PhD, Institute of Preventive Medicine, College of Public Health, National Taiwan University, No. 17, Hsu-Chou Road, Taipei, Taiwan 100; 886-2-3322-8017, fax 886-2-2392-0456

Received 9 March 2006 ,Revised 9 October 2006 ,Accepted 23 October 2006.

References 

  1. Stubbs PJ, Laycock J, Aghband-Zadeh J, et al. Circulating stress hormone and insulin concentrations in acute coronary syndromes: identification of insulin resistance on admission. Clin Sci (Lond). 1999;96:589–595
  2. Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355:773–778
  3. Malmberg K, Ryden L. Myocardial infarction in patients with diabetes mellitus. Eur Heart J. 1988;9:259–264
  4. Ishihara M, Inoue I, Kawagoe T, et al. Impact of acute hyperglycemia on left ventricular function after reperfusion therapy in patients with a first anterior wall acute myocardial infarction. Am Heart J. 2003;146:674–678
  5. Sewdarsen M, Vythilingum S, Jialal I, et al. Prognostic importance of admission plasma glucose in diabetic and non-diabetic patients with acute myocardial infarction. Q J Med. 1989;71:461–466
  6. Hadjadj S, Coisne D, Mauco G, et al. Prognostic value of admission plasma glucose and HbA in acute myocardial infarction. Diabet Med. 2004;21:305–310
  7. Norhammar AM, Ryden L, Malmberg K. Admission plasma glucose (Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients). Diabetes Care. 1999;22:1827–1831
  8. Tenerz A, Nilsson G, Forberg R, et al. Basal glucometabolic status has an impact on long-term prognosis following an acute myocardial infarction in non-diabetic patients. J Intern Med. 2003;254:494–503
  9. Timmer JR, van der Horst IC, Ottervanger JP, et al. Prognostic value of admission glucose in non-diabetic patients with myocardial infarction. Am Heart J. 2004;148:399–404
  10. Suleiman M, Hammerman H, Boulos M, et al. Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study. Circulation. 2005;111:754–760
  11. Wahab NN, Cowden EA, Pearce NJ, et al. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era?. J Am Coll Cardiol. 2002;40:1748–1754
  12. Wong VW, Ross DL, Park K, et al. Hyperglycemia: still an important predictor of adverse outcomes following AMI in the reperfusion era. Diabetes Res Clin Pract. 2004;64:85–91
  13. Anand SS, Xie CC, Mehta S, et al. Differences in the management and prognosis of women and men who suffer from acute coronary syndromes. J Am Coll Cardiol. 2005;46:1845–1851
  14. Bartnik M, Malmberg K, Norhammar A, et al. Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. Eur Heart J. 2004;25:1990–1997
  15. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. Eur Heart J. 2000;21:1502–1513
  16. Qiao Q, Pyorala K, Pyorala M, et al. Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose. Eur Heart J. 2002;23:1267–1275
  17. Bain RJ, Fox JP, Jagger J, et al. Serum cortisol levels predict infarct size and patient mortality. Int J Cardiol. 1992;37:145–150
  18. Vetter NJ, Strange RC, Adams W, et al. Initial metabolic and hormonal response to acute myocardial infarction. Lancet. 1974;1:284–288
  19. Oswald GA, Smith CC, Betteridge DJ, et al. Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. BMJ (Clin Res Ed). 1986;293:917–922
  20. Bain RJ, Fox JP, Jagger J, et al. Serum cortisol levels predict infarct size and patient mortality. Int J Cardiol. 1992;37:145–150
  21. Iwakura K, Ito H, Ikushima M, et al. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol. 2003;41:1–7
  22. Madsen JK, Haunsoe S, Helquist S, et al. Prevalence of hyperglycaemia and undiagnosed diabetes mellitus in patients with acute myocardial infarction. Acta Med Scand. 1986;220:329–332
  23. Husband DJ, Alberti KG, Julian DG. “Stress” hyperglycaemia during acute myocardial infarction: an indicator of pre-existing diabetes?. Lancet. 1983;2:179–181
  24. Chandalia HB, Gokani AH. Stress hyperglycaemia. Lancet. 1984;2:811–812
  25. Malmberg K, Ryden L, Efendic S, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol. 1995;26:57–65
  26. Malmberg K. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus: DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ. 1997;314:1512–1515
  27. Rytter L, Troelsen S, Beck-Nielsen H. Prevalence and mortality of acute myocardial infarction in patients with diabetes. Diabetes Care. 1985;8:230–234

 Supervising editor: Judd E. Hollander, MDAuthor contributions: C-WH conceived the study, obtained funding, drafted the manuscript, and collected the data. HHC supervised the conduct of the study and conducted statistical analysis. WH-HS, S-JC Y-SS, and C-PY contributed to the design of the study and contributed to the data collection. K-LC supervised the study procedure and provided statistical advice on study design, and all authors contributed substantially to its revision. K-LC takes responsibility for the paper as a whole.Funding and support: This project was funded by a grant from the National Science Council in Taiwan.Available online December 18, 2006.

PII: S0196-0644(06)02455-3

doi: 10.1016/j.annemergmed.2006.10.023

Annals of Emergency Medicine
Volume 49, Issue 5 , Pages 618-626 , May 2007

Article Tools

* Image Usage & Resolution